Reliance Life Sciences is a research-driven organization developing business opportunities in bio-therapeutics (plasma proteins, biosimilars and novel proteins), pharmaceuticals (later-generation, oncology generics), clinical research services, regenerative medicine (stem cells therapies) and molecular medicine. Reliance Life Sciences is part of the Promoter Group of Reliance Industries Limited. Reliance Life Sciences has launched three of the worldâ€™s first biosimilars, has the largest number of biosimilars in the market in India, and the highest number of biosimilars under development globally. It has the distinction of being the first integrated manufacturer of plasma proteins in South Asia. Reliance Life Sciences has catalyzed the emergence of regenerative medicine in the country, and has the highest experience with cord blood stem cell transplants in India. RLS is one of the few centres in the world offering a specialized range of tests in molecular medicine and molecular genetics.